Robert Wild
Founder chez Dracen Pharmaceuticals, Inc.
Profil
Robert Wild is the founder of Dracen Pharmaceuticals, Inc. He is currently an Executive In Residence at ShangPharma Innovation, Inc. He previously worked as Senior Director & Head at OSI Pharmaceuticals, Inc. and as Chief Scientific Officer & Senior VP-Research at Ignyta, Inc. He also served as Chief Scientific Officer at Eli Lilly & Co. Dr. Wild received his undergraduate and doctorate degrees from the University of Minnesota.
Postes actifs de Robert Wild
| Sociétés | Poste | Début |
|---|---|---|
ShangPharma Innovation, Inc.
 ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Consultant / Advisor | 01/03/2017 |
Dracen Pharmaceuticals, Inc.
 Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dracen Pharmaceuticals, Inc. develops immuno-metabolism drugs. The company was founded by Barbara Slusher, Jonathan D. Powell, Pavel Majer, and Rana Rais and is headquartered in New York, NY. | Founder | - |
Anciens postes connus de Robert Wild
| Sociétés | Poste | Fin |
|---|---|---|
| IGNYTA INC | Chief Tech/Sci/R&D Officer | 22/02/2016 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2010 |
| ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | - |
Formation de Robert Wild
| University of Minnesota | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Entreprise privées | 4 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA. | Health Technology |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Finance |
Dracen Pharmaceuticals, Inc.
Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dracen Pharmaceuticals, Inc. develops immuno-metabolism drugs. The company was founded by Barbara Slusher, Jonathan D. Powell, Pavel Majer, and Rana Rais and is headquartered in New York, NY. | Health Technology |
